CA3015358C - Proteines de fusion d'enzymes lysosomales therapeutiques ciblees, formulations associees et leurs utilisations - Google Patents
Proteines de fusion d'enzymes lysosomales therapeutiques ciblees, formulations associees et leurs utilisationsInfo
- Publication number
- CA3015358C CA3015358C CA3015358A CA3015358A CA3015358C CA 3015358 C CA3015358 C CA 3015358C CA 3015358 A CA3015358 A CA 3015358A CA 3015358 A CA3015358 A CA 3015358A CA 3015358 C CA3015358 C CA 3015358C
- Authority
- CA
- Canada
- Prior art keywords
- formulation
- concentration
- administration
- decline
- sodium phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
La présente invention concerne en général des protéines de fusion d'enzymes lysosomales thérapeutiques utiles pour traiter des maladies lysosomales, des formulations liquides comprenant de telles protéines de fusion et des procédés associés utiles pour traiter des maladies lysosomales chez des mammifères.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662299188P | 2016-02-24 | 2016-02-24 | |
| US62/299,188 | 2016-02-24 | ||
| US201662428221P | 2016-11-30 | 2016-11-30 | |
| US62/428,221 | 2016-11-30 | ||
| PCT/US2017/019343 WO2017147414A1 (fr) | 2016-02-24 | 2017-02-24 | Protéines de fusion d'enzymes lysosomales thérapeutiques ciblées, formulations associées et leurs utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3015358A1 CA3015358A1 (fr) | 2017-08-31 |
| CA3015358C true CA3015358C (fr) | 2025-09-23 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240263160A1 (en) | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins, Associated Formulations and Uses Thereof | |
| US11065307B2 (en) | Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety | |
| AU2011270672B2 (en) | Treatment of Sanfilippo Syndrome type B | |
| US10301369B2 (en) | Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins | |
| RU2671503C2 (ru) | Способы и композиции для доставки в цнс арилсульфатазы а | |
| KR20190103320A (ko) | 안정화된 알파-갈락토시다제를 이용하는 파브리의 치료를 위한 치료적 요법 | |
| CA3015358C (fr) | Proteines de fusion d'enzymes lysosomales therapeutiques ciblees, formulations associees et leurs utilisations | |
| HK40001779B (en) | Improved naglu fusion protein formulation | |
| HK40001779A (en) | Improved naglu fusion protein formulation | |
| US20220133863A1 (en) | Treatment of sanfilippo syndrome type b | |
| RU2783380C2 (ru) | Способы и композиции для доставки в цнс арилсульфатазы а | |
| WO2017015375A1 (fr) | Traitement d'une déficience cognitive de la mucopolysaccharidose de type iiia par administration intrathécale d'héparane n-sulfatase |